ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
117.67
-2.44 (-2.03%)
At close: Oct 29, 2025, 4:00 PM EDT
117.67
0.00 (0.00%)
After-hours: Oct 29, 2025, 5:20 PM EDT
ICU Medical Market Cap
ICU Medical has a market cap or net worth of $2.9 billion as of October 29, 2025. Its market cap has decreased by -33.46% in one year.
Market Cap
2.90B
Enterprise Value
4.01B
1-Year Change
-33.46%
Ranking
Category
Stock Price
$117.67
Market Cap Chart
Since December 1, 1998, ICU Medical's market cap has increased from $148.00M to $2.90B, an increase of 1,862.68%. That is a compound annual growth rate of 11.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 2.97B | -21.96% |
| Dec 31, 2024 | 3.80B | 57.79% |
| Dec 29, 2023 | 2.41B | -36.25% |
| Dec 30, 2022 | 3.78B | -25.08% |
| Dec 31, 2021 | 5.04B | 12.02% |
| Dec 31, 2020 | 4.50B | 16.33% |
| Dec 31, 2019 | 3.87B | -17.78% |
| Dec 31, 2018 | 4.70B | 8.20% |
| Dec 29, 2017 | 4.35B | 80.70% |
| Dec 30, 2016 | 2.41B | 33.55% |
| Dec 31, 2015 | 1.80B | 43.18% |
| Dec 31, 2014 | 1.26B | 34.06% |
| Dec 31, 2013 | 938.70M | 5.63% |
| Dec 31, 2012 | 888.70M | 42.79% |
| Dec 30, 2011 | 622.40M | 25.46% |
| Dec 31, 2010 | 496.10M | -8.06% |
| Dec 31, 2009 | 539.60M | 13.34% |
| Dec 31, 2008 | 476.10M | -4.76% |
| Dec 31, 2007 | 499.90M | -16.26% |
| Dec 29, 2006 | 597.00M | 9.72% |
| Dec 30, 2005 | 544.10M | 46.66% |
| Dec 31, 2004 | 371.00M | -20.74% |
| Dec 31, 2003 | 468.10M | -11.28% |
| Dec 31, 2002 | 527.60M | 36.86% |
| Dec 31, 2001 | 385.50M | 52.55% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.44B |
| Johnson & Johnson | 446.23B |
| AbbVie | 398.61B |
| UnitedHealth Group | 324.25B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 217.19B |